The role of procalcitonin as a biomarker for acute pulmonary exacerbation in subjects with cystic fibrosis and non-cystic fibrosis bronchiectasis

Creative Commons License

Mammadov F., Olgun Yildizel S., Kocakaya D., ARIKAN H., Cinar C., Eryuksel E., ...Daha Fazla

MARMARA MEDICAL JOURNAL, cilt.35, sa.2, ss.164-171, 2022 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5472/marumj.1114952
  • Dergi Adı: MARMARA MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.164-171
  • Anahtar Kelimeler: Cystic fibrosis, Bronchiectasis, Exacerbation, Infection, Procalcitonin, C-reactive protein, C-REACTIVE PROTEIN, SERUM PROCALCITONIN, ADULT PATIENTS, PATHOPHYSIOLOGY, INFECTIONS, GUIDANCE, THERAPY, MARKERS
  • Marmara Üniversitesi Adresli: Evet

Özet

Objective: Patients with cystic fibrosis (CF) and non-CF bronchiectasis are prone to exacerbations of pulmonary infections. C-reactive protein (CRP) and procalcitonin (PCT) are inflammatory markers. The aim of this study is to evaluate the role of CRP and PCT on exacerbations of CF and non-CF bronchiectasis.